CN103193830A - Preparation method of chiral ferrocene phosphine ligand - Google Patents

Preparation method of chiral ferrocene phosphine ligand Download PDF

Info

Publication number
CN103193830A
CN103193830A CN2013101018243A CN201310101824A CN103193830A CN 103193830 A CN103193830 A CN 103193830A CN 2013101018243 A CN2013101018243 A CN 2013101018243A CN 201310101824 A CN201310101824 A CN 201310101824A CN 103193830 A CN103193830 A CN 103193830A
Authority
CN
China
Prior art keywords
preparation
react
temperature
add
room temperature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2013101018243A
Other languages
Chinese (zh)
Inventor
陈卫平
张生勇
聂惠芳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fourth Military Medical University FMMU
Xian Modern Chemistry Research Institute
Original Assignee
Fourth Military Medical University FMMU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fourth Military Medical University FMMU filed Critical Fourth Military Medical University FMMU
Priority to CN2013101018243A priority Critical patent/CN103193830A/en
Publication of CN103193830A publication Critical patent/CN103193830A/en
Pending legal-status Critical Current

Links

Abstract

本发明公开了一种手性膦配体的制备方法,其用BuLi将Ugi′s胺在室温条件下锂化得到邻位活化的Ugi′s胺,再置于-60℃以下环境中,缓慢注入PCl3后升至室温反应过夜生成二氯代物的悬浊液,在加入过量的锂化物RLi或格氏试剂RMgX反应得到手性膦配体,或加入等摩尔的RLi或RMgX,缓慢升至室温反应后再加入过量的RLi或RMgX反应得到手性膦配体。本发明可在磷原子上方便地引入各种取代基,从而方便地改变膦配体的电子和立体性质。The invention discloses a preparation method of a chiral phosphine ligand, which uses BuLi to lithiate Ugi's amine at room temperature to obtain ortho-activated Ugi's amine, and then place it in an environment below -60°C, slowly After injecting PCl 3, rise to room temperature and react overnight to generate a suspension of dichlorides. After adding excess lithium compound RLi or Grignard reagent RMgX, react to obtain a chiral phosphine ligand, or add equimolar RLi or RMgX, and slowly rise to After reacting at room temperature, an excess of RLi or RMgX was added to react to obtain a chiral phosphine ligand. The invention can conveniently introduce various substituents on the phosphorus atom, thereby conveniently changing the electronic and stereoscopic properties of the phosphine ligand.

Description

手性二茂铁膦配体的制备方法Preparation method of chiral ferrocene phosphine ligand

技术领域 technical field

本发明涉及手性二茂铁膦配体的合成方法,属于有机合成技术领域。 The invention relates to a synthesis method of a chiral ferrocene phosphine ligand, belonging to the technical field of organic synthesis.

背景技术 Background technique

手性二茂铁膦配体是不对称催化领域中一类非常重要的配体(Arrayás R G, Angew. Chem. Int. Ed. 2006, 45, 7675-7676.)。1-(2-二苯膦基)二茂铁基-N,N-二甲基乙胺(PPFA)类化合物自身就是一类优秀的配体,(Hayashi T, Tetrahedron Letters. 1974, 15, 4405-4408.),同时PPFA类化合物也是合成许多手性二茂铁膦配体,如:Josiphos (Togni A, J. Am. Chem. Soc. 1994, 116, 4062-4066.)和BoPhoz (Boaz, N. W. Org. Lett. 2002, 4, 2421)的关键中间体。已知的PPFA类化合物合成方法均为将Ugi′s胺非对映选择性锂化,然后与二芳(烷)基氯化膦反应(Hayashi T, Bull. Chem. Soc. Jpn. 1980, 53, 1138-1151.)。已知的PPFA类化合物合成方法的缺点是许多二芳(烷)基氯化膦不易获得。 Chiral ferrocenephosphine ligands are a very important class of ligands in the field of asymmetric catalysis (Arrayás R G, Angew. Chem. Int. Ed. 2006, 45, 7675-7676.). 1-(2-diphenylphosphino) ferrocenyl- N , N -dimethylethylamine (PPFA) compound itself is a class of excellent ligands, (Hayashi T, Tetrahedron Letters. 1974, 15, 4405 -4408.), while PPFA compounds are also used to synthesize many chiral ferrocene phosphine ligands, such as: Josiphos (Togni A, J. Am. Chem. Soc. 1994, 116, 4062-4066.) and BoPhoz (Boaz, N. W. Org. Lett. 2002, 4 , 2421). The known synthetic methods of PPFA compounds are all Ugi's amine diastereoselective lithiation, and then react with diaryl (alkyl) phosphine chloride (Hayashi T, Bull. Chem. Soc. Jpn. 1980, 53 , 1138-1151.). A disadvantage of the known synthesis methods of PPFAs is that many diaryl(alkyl)phosphine chlorides are not readily available.

由于P-手性配体合成较其他手性配体难,所以发展的配体类型较少,由于P-手性配体手性中心离过渡金属较近往往会取得较好的立体选择性,因此,简便合成P-手性物质的方法一直是化学家努力的方向。一种已知的合成二茂铁类P-手性膦配体的方法是:将Ugi′s胺非对映选择性锂化,然后与芳(烷)基二氯化膦反应,再与一种有机金属试剂反应(Chen W, J. Am. Chem. Soc. 2006, 128, 3922. )。这一方法具有立体选择性高、收率高、操作简单等优点,用这种方法合成了许多优秀的配体如Trifer (Chen W, Angew. Chem. Int. Ed. 2007, 46, 4141)、ChenPhos(WO2007116081.)和C1-Trifer(WO2008101868.)。但这一方法的缺点是许多芳(烷)基二氯化膦不易获得,磷原子上的取代基只能进行有限的改变。 Since the synthesis of P-chiral ligands is more difficult than other chiral ligands, there are fewer types of ligands developed. Since the chiral center of P-chiral ligands is closer to the transition metal, better stereoselectivity is often achieved. Therefore, a simple method for synthesizing P-chiral substances has been the direction of chemists' efforts. A known method for the synthesis of ferrocene P-chiral phosphine ligands is: diastereoselective lithiation of Ugi's amines, followed by reaction with aryl (alkyl) phosphine dichlorides, followed by reaction with a Reaction of organometallic reagents (Chen W, J. Am. Chem. Soc. 2006 , 128, 3922 . ). This method has the advantages of high stereoselectivity, high yield, and simple operation. Many excellent ligands such as Trifer (Chen W, Angew. Chem. Int. Ed. 2007, 46, 4141), ChenPhos (WO2007116081.) and C1-Trifer (WO2008101868.). However, the disadvantage of this method is that many aryl(alkyl)phosphine dichlorides are not readily available, and the substituents on the phosphorus atom can only be changed to a limited extent.

众所周知,手性膦配体的电子和立体性质对催化活性和对映选择性起决定性作用,不同的底物和不同催化反应对手性膦配体的电子和立体性质有不同的要求,因此,发展方便合成各种不同电子和立体性质的膦配体具有非常重要的意义。 It is well known that the electronic and steric properties of chiral phosphine ligands play a decisive role in catalytic activity and enantioselectivity. Different substrates and different catalytic reactions have different requirements for the electronic and steric properties of chiral phosphine ligands. Therefore, the development It is of great significance to facilitate the synthesis of various phosphine ligands with different electronic and steric properties.

发明内容 Contents of the invention

本发明目的在于提供一种合成方法简便的手性二茂铁膦配体的制备方法。 The purpose of the present invention is to provide a preparation method of chiral ferrocene phosphine ligand with simple and convenient synthesis method.

本发明实现过程如下: The realization process of the present invention is as follows:

结构通式(I)所示化合物的制备方法,其特征在于包括以下步骤: The preparation method of the compound shown in general structural formula (I), is characterized in that comprising the following steps:

Figure 266964DEST_PATH_IMAGE001
Figure 266964DEST_PATH_IMAGE001

R1和R2独立地选自C1-C25的烷基, R 1 and R 2 are independently selected from C1-C25 alkyl groups,

或芳基,如:

Figure 184105DEST_PATH_IMAGE002
or aryl, such as:
Figure 184105DEST_PATH_IMAGE002

或杂芳基,如:

Figure 963842DEST_PATH_IMAGE003
or heteroaryl, such as:
Figure 963842DEST_PATH_IMAGE003

或环烷基,如:

Figure 359051DEST_PATH_IMAGE004
or cycloalkyl, such as:
Figure 359051DEST_PATH_IMAGE004

或二茂铁基,如:

Figure 298057DEST_PATH_IMAGE005
or ferrocenyl, such as:
Figure 298057DEST_PATH_IMAGE005

(1)有机金属锂试剂活化R构型或S构型Ugi′s胺后与PCl3反应得到二氯代物(II);  (1) The organometallic lithium reagent activates the R -configuration or S- configuration Ugi′s amine and reacts with PCl 3 to obtain the dichloride (II);

Figure 120520DEST_PATH_IMAGE006
Figure 120520DEST_PATH_IMAGE006

(2)加入二氯代物(II)2~3倍物质的量的RLi或RMgX,反应得到无P-手性的结构通式(I)所示化合物,其中R=R1=R2,X为卤素; (2) Add RLi or RMgX in an amount 2 to 3 times the amount of the dichloride (II), and react to obtain a compound shown in the general structural formula (I) without P-chirality, where R=R 1 =R 2 , X is halogen;

或者,先加入二氯代物(II)1~1.05倍摩尔量的R1Li或R1MgX反应得到单氯代物(III),然后再加入过量的R2Li或R2MgX反应得到P-手性的结构通式(I)所示化合物,其中R1≠R2Alternatively, first add 1-1.05 times the molar amount of dichloride (II) R 1 Li or R 1 MgX to react to obtain monochloride (III), and then add excess R 2 Li or R 2 MgX to react to obtain P-chiral The compound shown in general formula (I), wherein R 1 ≠ R 2 ,

Figure 387553DEST_PATH_IMAGE007
Figure 387553DEST_PATH_IMAGE007
.

上述步骤(1)中,有机金属锂试剂为甲基锂、正丁基锂、仲丁基锂、叔丁基锂、己基锂或苯基锂;加入有机金属锂试剂活化Ugi′s胺反应溶剂为甲基叔丁基醚、乙醚、甲苯或四氢呋喃,温度为-15℃~35℃;加入PCl3的温度为-120℃~-60℃,反应时间为6~18h。 In the above step (1), the organometallic lithium reagent is methyllithium, n-butyllithium, sec-butyllithium, tert-butyllithium, hexyllithium or phenyllithium; adding the organometallic lithium reagent to activate the Ugi's amine reaction solvent It is methyl tert-butyl ether, diethyl ether, toluene or tetrahydrofuran, and the temperature is -15°C to 35°C; the temperature for adding PCl 3 is -120°C to -60°C, and the reaction time is 6 to 18h.

上述步骤(2)中,加入RLi或RMgX的温度为-60℃~35℃。加入R1Li或R1MgX的温度为-120℃~-60℃,升至室温后反应1~6h。加入R2Li或R2MgX的温度为-60℃~35℃,R2Li或R2MgX的物质的量为单氯代物(III)的1~2倍,升至室温后反应4-16h。 In the above step (2), the temperature for adding RLi or RMgX is -60°C to 35°C. The temperature at which R 1 Li or R 1 MgX is added is -120°C to -60°C, and the reaction takes 1 to 6 hours after rising to room temperature. The temperature for adding R 2 Li or R 2 MgX is -60°C to 35°C, the amount of R 2 Li or R 2 MgX is 1-2 times that of the monochloride (III), and react for 4-16 hours after rising to room temperature .

本发明的优点与积极效果:可在磷原子上方便地引入各种取代基,方便地改变膦配体的电子和立体性质,从而可最大限度地扩展膦配体在不对催化反应中的应用范围。 Advantages and positive effects of the present invention: various substituents can be conveniently introduced on the phosphorus atom, and the electronic and stereoscopic properties of the phosphine ligand can be easily changed, thereby maximally expanding the scope of application of the phosphine ligand in unpaired catalytic reactions .

具体实施方式 Detailed ways

用BuLi将Ugi′s胺在室温条件下锂化得到邻位活化的Ugi′s胺,再置于-60℃以下,缓慢注入PCl3后升至室温反应生成二氯代物的悬浊液,所用膦试剂为PCl3,反应中所用锂试剂为有机金属锂试剂,如:甲基锂、正丁基锂、仲丁基锂、叔丁基锂、己基锂或苯基锂等。反应所用溶剂为甲基叔丁基醚、乙醚、甲苯或四氢呋喃等;锂化时反应温度为-15℃~35℃,加PCl3的温度为-120℃~-60℃,反应时间为6~18h,合成路线如下: Use BuLi to lithiate Ugi's amine at room temperature to obtain ortho-activated Ugi's amine, then place it below -60°C, slowly inject PCl 3 and rise to room temperature to react to form a suspension of dichloride. The phosphine reagent is PCl 3 , and the lithium reagent used in the reaction is an organometallic lithium reagent, such as: methyllithium, n-butyllithium, sec-butyllithium, tert-butyllithium, hexyllithium or phenyllithium. The solvent used in the reaction is methyl tert-butyl ether, diethyl ether, toluene or tetrahydrofuran, etc.; the reaction temperature during lithiation is -15°C to 35°C, the temperature for adding PCl3 is -120°C to -60°C, and the reaction time is 6 to 60°C. 18h, the synthetic route is as follows:

按照(

Figure 379965DEST_PATH_IMAGE009
)与 (
Figure 373329DEST_PATH_IMAGE010
)路线分别生成非P-手性和P-手性的(R)-S-PPFA类化合物: according to(
Figure 379965DEST_PATH_IMAGE009
)and (
Figure 373329DEST_PATH_IMAGE010
) route generates non-P-chiral and P-chiral ( R ) -S -PPFA compounds respectively:

() 在低温条件下加入过量的锂化物RLi或格氏试剂RMgX,然后升温至回流反应得到无P-手性的PPFA类化合物,反应时间为4-16h,RLi或RMgX的物质的量为二氯代物的2~3倍R为脂肪烃基、杂环或芳香烃基,合成路线如下: ( ) Add excess lithium compound RLi or Grignard reagent RMgX under low temperature conditions, then raise the temperature to reflux reaction to obtain PPFA compounds without P-chirality, the reaction time is 4-16h, the amount of substance of RLi or RMgX is dichloro 2 to 3 times of the R of the substitute is an aliphatic hydrocarbon group, a heterocyclic ring or an aromatic hydrocarbon group, and the synthetic route is as follows:

Figure 995164DEST_PATH_IMAGE011
Figure 995164DEST_PATH_IMAGE011

(

Figure 518549DEST_PATH_IMAGE010
) 在-60℃以下加入等摩尔的RLi或RMgX,然后缓慢升至室温反应2h,反应所用溶剂为甲基叔丁基醚、乙醚、甲苯或四氢呋喃等;加入RLi或RMgX的物质的量为二氯代物的1~1.05倍,缓慢升至室温反应得到单氯代物悬浊液时间为1~6h;再在低温下加入过量的RLi或RMgX,然后升温至回流反应4-16h得到P-手性的PPFA类化合物,R′Li或R′MgX的物质的量为单氯代物的1~2倍,升温至回流反应时间为4-16h;R和R′不相同,合成路线如下: (
Figure 518549DEST_PATH_IMAGE010
) Add equimolar RLi or RMgX below -60°C, then slowly rise to room temperature and react for 2 hours. The solvent used in the reaction is methyl tert-butyl ether, diethyl ether, toluene or tetrahydrofuran, etc.; 1-1.05 times that of chlorinated compounds, slowly rise to room temperature and react to obtain mono-chlorinated compound suspension. The PPFA compound, the amount of R'Li or R'MgX is 1 to 2 times that of the monochloride, and the reaction time is 4-16h when the temperature is raised to reflux; R and R' are different, and the synthetic route is as follows:

Figure 73027DEST_PATH_IMAGE012
Figure 73027DEST_PATH_IMAGE012

实施例1:制备(R)-S-1-(2-二苯膦基)二茂铁基-N,N-二甲基乙胺1 Example 1: Preparation of ( R ) -S -1-(2-diphenylphosphino)ferrocenyl- N , N -dimethylethylamine 1

向250 mL三口瓶中加入(R)-Ugi′s胺2.57 g(10 mmol),经抽真空/冲氮气循环后用注射器注入40 mL干燥过的甲基叔丁基醚,置于冰水浴中搅拌至溶解,缓慢注入s-BuLi 11 mL (1 M ,11 mmol),在冰水浴中反应2h生成砖红色絮状物沉淀,将三口瓶置于-78℃的低温反应器中,缓慢注入溶于10 mL甲基叔丁基醚的PCl3 0.96 mL(11 mmol),升至室温反应过夜得到二氯代物的悬浊液。 Add 2.57 g (10 mmol) of ( R )-Ugi's amine to a 250 mL three-necked flask, inject 40 mL of dried methyl tert-butyl ether with a syringe after vacuuming/nitrogen flushing cycle, and place in an ice-water bath Stir until dissolved, slowly inject 11 mL of s -BuLi (1 M , 11 mmol), react in an ice-water bath for 2 h to form a brick-red floc precipitate, place the three-necked flask in a low-temperature reactor at -78 °C, and slowly inject the solution Add 0.96 mL (11 mmol) of PCl 3 in 10 mL of methyl tert-butyl ether to room temperature and react overnight to obtain a suspension of the dichloro compound.

向100 mL单口瓶中加入溴苯2.4 mL(23 mmol),经抽真空/冲氮气循环后用注射器注入40 mL干燥过的甲基叔丁基醚,置于-40℃的低温反应器中搅拌至溶解,缓慢注入n-BuLi 15 mL (1.6 M, 24 mmol),缓慢升至室温反应2h生成苯基锂化物。 Add 2.4 mL (23 mmol) of bromobenzene into a 100 mL single-necked bottle, inject 40 mL of dried methyl tert-butyl ether with a syringe after vacuum/nitrogen cycle, and place in a low-temperature reactor at -40°C to stir Until dissolved, slowly inject 15 mL of n -BuLi (1.6 M, 24 mmol), slowly rise to room temperature and react for 2 hours to form phenyllithium.

将二氯代物的悬浊液置于-20℃低温反应器中,用双针头将苯基锂化物加入二氯代物的悬浊液中,升温至回流反应8h,过滤除去不溶物,依次用水、饱和食盐水洗涤,蒸干溶剂柱层析得橘红色固体产物2.4 g,产率54.4%。 Place the suspension of the dichloride in a low-temperature reactor at -20°C, add the phenyllithium compound into the suspension of the dichloride with a double needle, raise the temperature to reflux for 8 hours, remove the insoluble matter by filtration, and then use water, Washed with saturated brine, evaporated to dryness, and column chromatography gave 2.4 g of an orange-red solid product with a yield of 54.4%.

mp 141-143℃; 

Figure 439286DEST_PATH_IMAGE013
 -350.9 (c = 0.25, CHCl3); 1H NMR (500 Hz, CDCl3):δ 7.62-7.56 (m, 2H), 7.37-7.32 (m, 3H), 7.22-7.14 (m, 5H), 4.37 (s, 1H), 4.25-4.24 (m, 1H), 4.16-4.14 (dd, J = 2.5, 2.5 Hz, 1H), 3.94 (s, 5H), 3.86 (s, 1H), 1.77 (s, 6H), 1.27-1.26 (d, J = 7 Hz, 3H)。 mp 141-143°C;
Figure 439286DEST_PATH_IMAGE013
-350.9 (c = 0.25, CHCl 3 ); 1 H NMR (500 Hz, CDCl 3 ): δ 7.62-7.56 (m, 2H), 7.37-7.32 (m, 3H), 7.22-7.14 (m, 5H), 4.37 (s, 1H), 4.25-4.24 (m, 1H), 4.16-4.14 (dd, J = 2.5, 2.5 Hz, 1H), 3.94 (s, 5H), 3.86 (s, 1H), 1.77 (s, 6H), 1.27-1.26 (d, J = 7 Hz, 3H).

实施例2:制备(R)-S-1-[2-二(3,5-二甲基苯基)膦基]二茂铁基-N,N-二甲基乙胺2 Example 2: Preparation of ( R ) -S -1-[2-bis(3,5-dimethylphenyl)phosphino]ferrocenyl- N , N -dimethylethylamine 2

制备方法同实施例1,得到橘红色油状物 2.2 g,产率44.2%。 The preparation method was the same as in Example 1, and 2.2 g of orange-red oil was obtained, with a yield of 44.2%.

Figure 714410DEST_PATH_IMAGE013
 -278.5 (c = 0.25, CHCl3); 1H NMR (500 Hz, CDCl3) δ 7.25-7.23 (m, 2H), 6.98 (s, 1H), 6.80-6.78 (m, 3H), 4.35 (s, 1H), 4.23-4.22 (m, 1H), 4.10-4.08 (dd, J = 2.5, 2.5 Hz, 1H), 3.92 (s, 5H), 3.87 (s, 1H), 2.32 (s, 6H), 2.18 (s, 6H), 1.81 (s, 6H), 1.28-1.27 (d, J = 7 Hz, 3H)。
Figure 714410DEST_PATH_IMAGE013
-278.5 (c = 0.25, CHCl 3 ); 1 H NMR (500 Hz, CDCl 3 ) δ 7.25-7.23 (m, 2H), 6.98 (s, 1H), 6.80-6.78 (m, 3H), 4.35 (s , 1H), 4.23-4.22 (m, 1H), 4.10-4.08 (dd, J = 2.5, 2.5 Hz, 1H), 3.92 (s, 5H), 3.87 (s, 1H), 2.32 (s, 6H), 2.18 (s, 6H), 1.81 (s, 6H), 1.28-1.27 (d, J = 7 Hz, 3H).

实施例3:制备(R)-S-1-[2-二(3,5-二叔丁基基苯基)膦基]二茂铁基-N,N-二甲基乙胺3 Example 3: Preparation of ( R ) -S -1-[2-bis(3,5-di-tert-butylphenyl)phosphino]ferrocenyl- N , N -dimethylethylamine 3

制备方法同实施例1,得到黄色泡沫状固体3.1 g,产率46.6%。 The preparation method was the same as in Example 1, and 3.1 g of a yellow foamy solid was obtained, with a yield of 46.6%.

Figure 482515DEST_PATH_IMAGE013
 -246.8 (c = 0.25, CH2Cl2); 1H NMR (500 Hz, CDCl3) δ 7.65-7.55 (dd, J = 2, 1.5 Hz, 2H), 7.44 (s, 1H), 7.25-7.21 (m, 3H), 4.37 (s, 1H), 4.26 (s, 1H), 4.21-4.17 (dd, J = 3, 2.5 Hz, 1H), 3.97 (s, 5H), 3.90 (s, 1H), 1.73 (s, 6H), 1.36 (s, 18H), 1.34-1.30 (d, J = 6.5 Hz, 3H), 1.26 (s, 18H); 31P NMR (202 Hz, CDCl3) δ -22.78 (s).
Figure 482515DEST_PATH_IMAGE013
-246.8 (c = 0.25, CH 2 Cl 2 ); 1 H NMR (500 Hz, CDCl 3 ) δ 7.65-7.55 (dd, J = 2, 1.5 Hz, 2H), 7.44 (s, 1H), 7.25-7.21 (m, 3H), 4.37 (s, 1H), 4.26 (s, 1H), 4.21-4.17 (dd, J = 3, 2.5 Hz, 1H), 3.97 (s, 5H), 3.90 (s, 1H), 1.73 (s, 6H), 1.36 (s, 18H), 1.34-1.30 (d, J = 6.5 Hz, 3H), 1.26 (s, 18H); 31 P NMR (202 Hz, CDCl 3 ) δ -22.78 (s ).

实施例4:制备(R)-S-1-[2-二(4-溴苯基)膦基]二茂铁基-N,N-二甲基乙胺4 Example 4: Preparation of ( R ) -S -1-[2-bis(4-bromophenyl)phosphino]ferrocenyl- N , N -dimethylethylamine 4

制备方法同实施例1,得到黄色泡沫状固体1.38 g,产率23.1%。 The preparation method was the same as in Example 1, and 1.38 g of a yellow foamy solid was obtained, with a yield of 23.1%.

 -302.8 (c = 0.25, CH2Cl2); 1H NMR (500 Hz, CDCl3) δ 7.52-7.46 (d, J = 7.5 Hz, 2H), 7.44-7.36 (m, 2H), 7.34-7.28 (d, J = 7.5 Hz, 2H), 7.04-6.98 (m, 2H), 4.39 (s, 1H), 4.20 (s, 1H), 4.15-4.10 (d, J = 4.5 Hz, 1H), 3.96 (s, 5H), 3.77 (s, 1H), 1.76 (s, 6H), 1.16-1.12 (d, J = 3 Hz, 3H); 31P NMR (202 Hz, CDCl3) δ -24.36 (s)。 -302.8 (c = 0.25, CH 2 Cl 2 ); 1 H NMR (500 Hz, CDCl 3 ) δ 7.52-7.46 (d, J = 7.5 Hz, 2H), 7.44-7.36 (m, 2H), 7.34-7.28 (d, J = 7.5 Hz, 2H), 7.04-6.98 (m, 2H), 4.39 (s, 1H), 4.20 (s, 1H), 4.15-4.10 (d, J = 4.5 Hz, 1H), 3.96 ( s, 5H), 3.77 (s, 1H), 1.76 (s, 6H), 1.16-1.12 (d, J = 3 Hz, 3H); 31 P NMR (202 Hz, CDCl 3 ) δ -24.36 (s).

实施例5:制备(R)-S-1-[2-(二(2-噻吩基)膦基]二茂铁基-N,N-二甲基乙胺5 Example 5: Preparation of ( R ) -S -1-[2-(bis(2-thienyl)phosphino]ferrocenyl- N , N -dimethylethylamine 5

制备方法同实施例1,橘红色固体产物2.38 g,产率52.5%。 The preparation method was the same as in Example 1, the orange-red solid product was 2.38 g, and the yield was 52.5%.

mp 118.6-119.8℃; 

Figure 546603DEST_PATH_IMAGE013
 -424 (c = 0.25, CH2Cl2); 1H NMR (500 Hz, CDCl3) δ 7.60-7.56 (d, J = 5 Hz, 1H), 7.52-7.46 (m, 1H), 7.36-7.32 (d, J = 5 Hz, 1H), 7.15-7.05 (m, 2H), 7.00-6.90 (m, 1H), 4.37 (s, 1H), 4.32 (s, 1H), 4.27 (s, 1H), 4.20-4.10 (m, 1H), 3.95 (s, 5H), 1.80 (s, 6H), 1.30-1.20 (d, J = 7 Hz, 3H); 31P NMR (202 Hz, CDCl3) δ -52.08 (s)。 mp 118.6-119.8℃;
Figure 546603DEST_PATH_IMAGE013
-424 (c = 0.25, CH 2 Cl 2 ); 1 H NMR (500 Hz, CDCl 3 ) δ 7.60-7.56 (d, J = 5 Hz, 1H), 7.52-7.46 (m, 1H), 7.36-7.32 (d, J = 5 Hz, 1H), 7.15-7.05 (m, 2H), 7.00-6.90 (m, 1H), 4.37 (s, 1H), 4.32 (s, 1H), 4.27 (s, 1H), 4.20-4.10 (m, 1H), 3.95 (s, 5H), 1.80 (s, 6H), 1.30-1.20 (d, J = 7 Hz, 3H); 31 P NMR (202 Hz, CDCl 3 ) δ -52.08 (s).

实施例6:制备(R)-S-1-[2-二(4-苯基苯基)膦基]二茂铁基-N,N-二甲基乙胺6 Example 6: Preparation of ( R ) -S -1-[2-bis(4-phenylphenyl)phosphino]ferrocenyl- N , N -dimethylethylamine 6

制备方法同实施例1,得到橘黄色固体2.5 g,产率42.0%。 The preparation method was the same as in Example 1, and 2.5 g of an orange-yellow solid was obtained, with a yield of 42.0%.

mp 95.6-97℃;  -387.6 (c = 0.25, CH2Cl2); 1H NMR (500 Hz, CDCl3) δ 7.80-7.74 (m, 2H), 7.72-7.66 (m, 4H), 7.66-7.62 (d, J = 7.5 Hz, 2H), 7.54-7.32 (m, 10H), 4.46 (s, 1H), 4.34 (s, 1H), 4.30-4.20 (dd, J = 2, 1.5 Hz, 1H), 4.04 (s, 5H), 4.00 (s, 1H), 1.88 (s, 6H), 1.36-1.32 (d, J = 6 Hz, 3H); 31P NMR (202 Hz, CDCl3) δ -24.35 (s)。 mp 95.6-97℃; -387.6 (c = 0.25, CH 2 Cl 2 ); 1 H NMR (500 Hz, CDCl 3 ) δ 7.80-7.74 (m, 2H), 7.72-7.66 (m, 4H), 7.66-7.62 (d, J = 7.5 Hz, 2H), 7.54-7.32 (m, 10H), 4.46 (s, 1H), 4.34 (s, 1H), 4.30-4.20 (dd, J = 2, 1.5 Hz, 1H), 4.04 (s, 5H ), 4.00 (s, 1H), 1.88 (s, 6H), 1.36-1.32 (d, J = 6 Hz, 3H); 31 P NMR (202 Hz, CDCl 3 ) δ -24.35 (s).

实施例7:(R)-S-1-[2-二正癸烷基膦基)]二茂铁基-N,N-二甲基乙胺7 Example 7: ( R ) -S -1-[2-Di-n-decylphosphino)]ferrocenyl- N , N -dimethylethylamine 7

二氯代物制备同实施例1。 The preparation of dichloride is the same as in Example 1.

向架有冷凝管的100 mL三口瓶中加入0.96 g(40 mmol)镁带,注入干燥的乙醚缓慢搅拌,慢慢注入0.8 mL(3.8 mmol)溴代正癸烷引发反应至回流,然后滴加溶于20 mL无水乙醚的7.5 mL (36.2 mmol)溴代正癸烷,加完后回流反应4h,静置待用。 Add 0.96 g (40 mmol) magnesium strips to a 100 mL three-neck flask with a condenser tube, inject dry diethyl ether and stir slowly, slowly inject 0.8 mL (3.8 mmol) n-bromodecane to initiate the reaction to reflux, and then add dropwise Dissolve 7.5 mL (36.2 mmol) n-bromodecane in 20 mL of anhydrous ether, reflux for reaction for 4 hours after the addition, and let stand for use.

将二氯代物的悬浊液置于-20℃低温反应器中,用双针头将格氏试剂加入二氯代物的悬浊液中,升温至回流反应8h,过滤除去不溶物,依次用水、饱和食盐水洗涤,蒸干溶剂柱层析得橘红色油状物2.6 g,产率45.7%。 Place the suspension of the dichloride in a low-temperature reactor at -20°C, add the Grignard reagent into the suspension of the dichloride with a double needle, raise the temperature to reflux for 8 hours, remove the insoluble matter by filtration, and then water, saturated Washed with brine, evaporated to dryness and solvent column chromatography gave 2.6 g of an orange-red oily substance, with a yield of 45.7%.

Figure 248028DEST_PATH_IMAGE013
 -92.1 (c = 0.7, CH2Cl2); 1H NMR (500 Hz, CDCl3) δ 4.26 (s, 1H), 4.19 (s, 1H), 4.11 (s, 1H), 4.10-4.02 (m, 6H), 2.06 (s, 6H), 1.70-1.43 (m, 6H), 1.42-1.16 (m, 33H), 0.92-0.83 (m, 6H); 31P NMR (202 Hz, CDCl3) δ -39.17 (s)。
Figure 248028DEST_PATH_IMAGE013
-92.1 (c = 0.7, CH 2 Cl 2 ); 1 H NMR (500 Hz, CDCl 3 ) δ 4.26 (s, 1H), 4.19 (s, 1H), 4.11 (s, 1H), 4.10-4.02 (m , 6H), 2.06 (s, 6H), 1.70-1.43 (m, 6H), 1.42-1.16 (m, 33H), 0.92-0.83 (m, 6H); 31 P NMR (202 Hz, CDCl 3 ) δ - 39.17(s).

实施例8:制备(R)-S-1-[2-[(R)-(2-邻甲氧基苯基)(苯基)]膦基]二茂铁基-N,N-二甲基乙胺8 Example 8: Preparation of ( R ) -S -1-[2-[( R )-(2-o-methoxyphenyl)(phenyl)]phosphino]ferrocenyl- N , N -dimethyl Ethylamine 8

二氯代物制备同实施例1。 The preparation of dichloride is the same as in Example 1.

向100 mL单口瓶中加入邻甲氧基溴苯1.25 mL(10 mmol),经抽真空/冲氮气循环后用注射器注入20 mL干燥过的甲基叔丁基醚,置于-40℃的低温反应器中搅拌至溶解,缓慢注入n-BuLi 6.6 mL (1.6 M, 10.56 mmol),升至室温反应2h生成苯基锂化物;将二氯代物的悬浊液置于-70℃低温反应器中,用双针头将苯基锂化物加入二氯代物的悬浊液中,升至室温反应2h得到单氯代物。 Add 1.25 mL (10 mmol) of o-methoxybromobenzene into a 100 mL single-necked bottle, inject 20 mL of dried methyl tert-butyl ether with a syringe after vacuuming/nitrogen cycle, and place at -40°C Stir in the reactor until dissolved, slowly inject 6.6 mL (1.6 M, 10.56 mmol) of n -BuLi, rise to room temperature and react for 2 hours to generate phenyllithium; place the suspension of dichloride in a low-temperature reactor at -70°C , Add the phenyl lithium compound to the suspension of the dichloride with a double needle, rise to room temperature and react for 2h to obtain the monochloride.

向100 mL单口瓶中加入溴苯1.26 mL(12 mmol),经抽真空/冲氮气循环后用注射器注入20 mL干燥过的甲基叔丁基醚,置于-40℃的低温反应器中搅拌至溶解,缓慢注入n-BuLi 8 mL (1.6 M, 12.8 mmol),升至室温反应2h生成锂化物;将单氯代物的悬浊液置于-20℃低温反应器中,用双针头将锂化物加入单氯代物的悬浊液中,升温至回流反应8h,过滤除去不溶物,依次用水、饱和食盐水洗涤,蒸干溶剂柱层析得橘红色固体产物2.1 g,44.6%。 Add 1.26 mL (12 mmol) of bromobenzene into a 100 mL single-necked bottle, inject 20 mL of dried methyl tert-butyl ether with a syringe after vacuuming/nitrogen cycle, and place in a low-temperature reactor at -40°C to stir Until dissolved, slowly inject 8 mL of n -BuLi (1.6 M, 12.8 mmol), rise to room temperature and react for 2 hours to generate lithium compounds; place the suspension of monochlorides in a low-temperature reactor at -20°C, and use a double needle to inject lithium The compound was added to the suspension of monochloride, heated to reflux for 8 hours, filtered to remove insoluble matter, washed with water and saturated brine in turn, and evaporated to dryness. Column chromatography gave 2.1 g of orange-red solid product, 44.6%.

mp 127. -128.4℃;  -237.2 (c = 0.25, CH2Cl2); 1H NMR (500 Hz, CDCl3) δ 7.36-7.30 (m, 1H), 7.22-7.10 (m, 6H), 6.98-6.92 (m, 1H), 6.90-6.84 (m, 1H), 4.37 (s, 1H), 4.25 (s, 1H), 4.32-4.05 (dd, J = 2.5, 3 Hz, 1H), 3.97 (s, 5H), 3.96-3.93 (m, 1H), 3.93 (s, 3H), 1.79 (s, 6H), 1.34-1.24 (d, J = 1.5 Hz, 3H); 31P NMR (202 Hz, CDCl3) δ -40.51 (s)。 mp 127. -128.4℃; -237.2 (c = 0.25, CH 2 Cl 2 ); 1 H NMR (500 Hz, CDCl 3 ) δ 7.36-7.30 (m, 1H), 7.22-7.10 (m, 6H), 6.98-6.92 (m, 1H) , 6.90-6.84 (m, 1H), 4.37 (s, 1H), 4.25 (s, 1H), 4.32-4.05 (dd, J = 2.5, 3 Hz, 1H), 3.97 (s, 5H), 3.96-3.93 (m, 1H), 3.93 (s, 3H), 1.79 (s, 6H), 1.34-1.24 (d, J = 1.5 Hz, 3H); 31 P NMR (202 Hz, CDCl 3 ) δ -40.51 (s) .

实施例9:制备(R)-S-1-[2-[(S)-(2-邻甲氧基苯基)(苯基)]膦基]二茂铁基-N,N-二甲基乙胺9 Example 9: Preparation of ( R ) -S -1-[2-[( S )-(2-o-methoxyphenyl)(phenyl)]phosphino]ferrocenyl- N , N -dimethyl Ethylamine 9

二氯代物制备同实施例1。 The preparation of dichloride is the same as in Example 1.

向100 mL单口瓶中加入溴苯1.05 mL(10 mmol),经抽真空/冲氮气循环后用注射器注入20 mL干燥过的甲基叔丁基醚,置于-40℃的低温反应器中搅拌至溶解,缓慢注入n-BuLi 6.6 mL (1.6 M, 10.56 mmol),升至室温反应2h生成苯基锂化物;将二氯代物的悬浊液置于-70℃低温反应器中,用双针头将苯基锂化物加入二氯代物的悬浊液中,升至室温反应2h得到单氯代物。 Add 1.05 mL (10 mmol) of bromobenzene into a 100 mL single-necked bottle, inject 20 mL of dried methyl tert-butyl ether with a syringe after vacuuming/nitrogen cycle, and place in a low-temperature reactor at -40°C to stir Until dissolved, slowly inject 6.6 mL (1.6 M, 10.56 mmol) of n -BuLi, rise to room temperature and react for 2 hours to generate phenyllithium; place the suspension of dichloride in a low-temperature reactor at -70°C, and Add the phenyllithium compound to the suspension of the dichloride, rise to room temperature and react for 2 hours to obtain the monochloride.

向100 mL单口瓶中加入邻甲氧基溴苯1.5 mL(12 mmol),经抽真空/冲氮气循环后用注射器注入20 mL干燥过的甲基叔丁基醚,置于-40℃的低温反应器中搅拌至溶解,缓慢注入n-BuLi 8 mL (1.6 M, 12.8 mmol),升至室温反应2h生成锂化物;将单氯代物的悬浊液置于-20℃低温反应器中,用双针头将锂化物加入单氯代物的悬浊液中,升温至回流反应8h,过滤除去不溶物,依次用水、饱和食盐水洗涤,蒸干溶剂柱层析得橘红色固体产物1.9 g,40.3%。 Add 1.5 mL (12 mmol) of o-methoxybromobenzene into a 100 mL single-necked bottle, inject 20 mL of dried methyl tert-butyl ether with a syringe after vacuuming/nitrogen cycle, and place at -40 °C Stir in the reactor until dissolved, slowly inject n -BuLi 8 mL (1.6 M, 12.8 mmol), rise to room temperature and react for 2 hours to generate lithium compounds; place the monochloride suspension in a -20°C low-temperature reactor, Add the lithium compound into the suspension of the monochloride with double needles, raise the temperature to reflux for 8 hours, remove the insoluble matter by filtration, wash with water and saturated brine successively, and evaporate the solvent to dryness. .

mp 127. -128.4℃; 

Figure 970314DEST_PATH_IMAGE013
 -106 (c = 0.25, CH2Cl2); 1H NMR (500 Hz, CDCl3) δ 7.34-7.28 (m, 1H), 7.18-7.08 (m, 2H), 6.98-6.80 (m, 4H), 6.78-6.72 (m, 1H), 6.70-6.65 (m, 1H), 4.39 (s, 1H), 4.26 (s, 1H), 4.20-4.08 (dd, J = 3.5, 3.5 Hz, 1H), 3.97 (s, 5H), 3.90 (s, 1H), 3.58 (s, 3H), 1.84 (s, 6H), 1.35-1.25 (d, J = 6.5 Hz, 3H); 31P NMR (202 Hz, CDCl3) δ -53.36 (s)。 mp 127. -128.4℃;
Figure 970314DEST_PATH_IMAGE013
-106 (c = 0.25, CH 2 Cl 2 ); 1 H NMR (500 Hz, CDCl 3 ) δ 7.34-7.28 (m, 1H), 7.18-7.08 (m, 2H), 6.98-6.80 (m, 4H) , 6.78-6.72 (m, 1H), 6.70-6.65 (m, 1H), 4.39 (s, 1H), 4.26 (s, 1H), 4.20-4.08 (dd, J = 3.5, 3.5 Hz, 1H), 3.97 ( s , 5H), 3.90 (s, 1H), 3.58 (s, 3H), 1.84 (s, 6H), 1.35-1.25 (d, J = 6.5 Hz, 3H ); ) δ -53.36 (s).

 实施例10:制备(R)-S-1-[2-[(S)-(3,5-二甲基苯基)(苯基)]膦基]二茂铁基-N,N-二甲基乙胺10 Example 10: Preparation of ( R ) -S -1-[2-[( S )-(3,5-dimethylphenyl)(phenyl)]phosphino]ferrocenyl- N , N -di Methylethylamine 10

制备方法同实施例9,黄色固体产物2.3 g,产率49.0%。 The preparation method was the same as in Example 9, 2.3 g of a yellow solid product, and the yield was 49.0%.

mp 177.3-178.6℃;  -317.6 (c = 0.25, CH2Cl2); 1H NMR (500 Hz, CDCl3) δ 7.72-7.60 (m, 2H), 7.44-7.36 (m, 3H), 6.90-6.80 (m, 3H), 4.43 (s, 1H), 4.28 (s, 1H), 4.22-4.12 (d, J = 4 Hz, 1H), 3.96 (s, 5H), 3.91 (s, 1H), 2.23 (s, 6H), 1.87 (s, 6H), 1.44-1.28 (d, J = 1.5 Hz, 3H)。 mp 177.3-178.6℃; -317.6 (c = 0.25, CH 2 Cl 2 ); 1 H NMR (500 Hz, CDCl 3 ) δ 7.72-7.60 (m, 2H), 7.44-7.36 (m, 3H), 6.90-6.80 (m, 3H) , 4.43 (s, 1H), 4.28 (s, 1H), 4.22-4.12 (d, J = 4 Hz, 1H), 3.96 (s, 5H), 3.91 (s, 1H), 2.23 (s, 6H), 1.87 (s, 6H), 1.44-1.28 (d, J = 1.5 Hz, 3H).

Claims (7)

1.结构通式(I)所示化合物的制备方法,其特征在于包括以下步骤: 1. The preparation method of the compound shown in general structural formula (I), it is characterized in that comprising the following steps:
Figure 2013101018243100001DEST_PATH_IMAGE002
Figure 2013101018243100001DEST_PATH_IMAGE002
R1和R2独立地选自C1-C25的烷基,或芳基、杂芳基、环烷基、二茂铁基,  R 1 and R 2 are independently selected from C1-C25 alkyl, or aryl, heteroaryl, cycloalkyl, ferrocenyl, (1)有机金属锂试剂活化R构型或S构型Ugi′s胺后与PCl3反应得到二氯代物(II);  (1) The organometallic lithium reagent activates the R -configuration or S- configuration Ugi′s amine and reacts with PCl 3 to obtain the dichloride (II);
Figure 2013101018243100001DEST_PATH_IMAGE004
Figure 2013101018243100001DEST_PATH_IMAGE004
(2)加入二氯代物(II)2~3倍物质的量的RLi或RMgX,反应得到无P-手性的结构通式(I)所示化合物,其中R=R1=R2,X为卤素; (2) Add RLi or RMgX in an amount 2 to 3 times the amount of the dichloride (II), and react to obtain a compound shown in the general structural formula (I) without P-chirality, where R=R 1 =R 2 , X is halogen; 或者,先加入二氯代物(II)1~1.05倍摩尔量的R1Li或R1MgX反应得到单氯代物(III),然后再加入过量的R2Li或R2MgX反应得到P-手性的结构通式(I)所示化合物,其中R1≠R2Alternatively, first add 1-1.05 times the molar amount of dichloride (II) R 1 Li or R 1 MgX to react to obtain monochloride (III), and then add excess R 2 Li or R 2 MgX to react to obtain P-chiral The compound shown in general formula (I), wherein R 1 ≠ R 2 ,
Figure 2013101018243100001DEST_PATH_IMAGE006
Figure 2013101018243100001DEST_PATH_IMAGE006
.
2. 根据权利要求1所述化合物的制备方法,其特征在于:步骤(1)中,有机金属锂试剂为甲基锂、正丁基锂、仲丁基锂、叔丁基锂、己基锂或苯基锂。 2. The preparation method of the compound according to claim 1, characterized in that: in step (1), the organometallic lithium reagent is methyllithium, n-butyllithium, sec-butyllithium, tert-butyllithium, hexyllithium or Phenyllithium. 3.根据权利要求1所述化合物的制备方法,其特征在于:步骤(1)中,加入有机金属锂试剂活化Ugi′s胺反应溶剂为甲基叔丁基醚、乙醚、甲苯或四氢呋喃,温度为-15℃~35℃。 3. according to the preparation method of the described compound of claim 1, it is characterized in that: in step (1), add organometallic lithium reagent activation Ugi's amine reaction solvent is methyl tert-butyl ether, ether, toluene or tetrahydrofuran, temperature -15°C to 35°C. 4.根据权利要求1所述化合物的制备方法,其特征在于:步骤(1)中,加入PCl3的温度为-120℃~-60℃,反应时间为6~18h。 4. The preparation method of the compound according to claim 1, characterized in that: in step (1), the temperature of adding PCl 3 is -120°C ~ -60°C, and the reaction time is 6 ~ 18h. 5.根据权利要求1所述化合物的制备方法,其特征在于,其特征在于:步骤(2)中,加入RLi或RMgX的温度为-60℃~35℃。 5. The preparation method of the compound according to claim 1, characterized in that: in step (2), the temperature of adding RLi or RMgX is -60°C to 35°C. 6.根据权利要求1所述化合物的制备方法,其特征在于,其特征在于:步骤(2)中,加入R1Li或R1MgX的温度为-120℃~-60℃,升至室温后反应1~6h。 6. The preparation method of the compound according to claim 1, characterized in that: in step (2), the temperature of adding R 1 Li or R 1 MgX is -120°C ~ -60°C, after rising to room temperature Reaction 1 ~ 6h. 7.根据权利要求1所述化合物的制备方法,其特征在于:步骤(2)中,加入R2Li或R2MgX的温度为-60℃~35℃,R2Li或R2MgX的物质的量为单氯代物(III)的1~2倍,升至室温后反应4-16h。 7. The preparation method of the compound according to claim 1, characterized in that: in step (2), the temperature of adding R 2 Li or R 2 MgX is -60°C to 35°C, and the substance of R 2 Li or R 2 MgX The amount is 1 to 2 times that of the monochloride (III), and react for 4-16 hours after rising to room temperature.
CN2013101018243A 2013-03-28 2013-03-28 Preparation method of chiral ferrocene phosphine ligand Pending CN103193830A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2013101018243A CN103193830A (en) 2013-03-28 2013-03-28 Preparation method of chiral ferrocene phosphine ligand

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2013101018243A CN103193830A (en) 2013-03-28 2013-03-28 Preparation method of chiral ferrocene phosphine ligand

Publications (1)

Publication Number Publication Date
CN103193830A true CN103193830A (en) 2013-07-10

Family

ID=48716663

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2013101018243A Pending CN103193830A (en) 2013-03-28 2013-03-28 Preparation method of chiral ferrocene phosphine ligand

Country Status (1)

Country Link
CN (1) CN103193830A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103804432A (en) * 2014-02-25 2014-05-21 中国人民解放军第四军医大学 Double-functionalized amine-thiourea organic catalyst based on ferrocene and preparation method and application thereof
CN103831133A (en) * 2014-02-25 2014-06-04 中国人民解放军第四军医大学 Bi-functional phosphine thiourea organic catalyst based on ferrocene skeleton as well as preparation method and application thereof
CN104592313A (en) * 2014-12-30 2015-05-06 陕西师范大学 Double functional hydrogen bond organic catalyst based on ferrocene as well as preparation method and application of double functional hydrogen bond organic catalyst
CN107098932A (en) * 2017-06-29 2017-08-29 管德新 A kind of synthetic method of benzyl class part available for hydroformylation reaction
CN114085251A (en) * 2021-11-02 2022-02-25 中国人民解放军空军军医大学 A class of chiral ferrocene-spiro-ring skeleton bisphosphine ligands and preparation method thereof
CN114085250A (en) * 2021-11-02 2022-02-25 中国人民解放军空军军医大学 Preparation and application of P-chiral phosphine-oxazoline ligand metal complex catalyst containing Ugi's amine building blocks
CN116178455A (en) * 2023-04-26 2023-05-30 江苏欣诺科催化剂股份有限公司 Preparation method of ferrocene chiral phosphine ligand

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008101868A1 (en) * 2007-02-20 2008-08-28 Solvias Ag Bis (ferrocenylphosphino) ferrocene ligands used in asymmetric hydrogenation reactions
CN101421285A (en) * 2006-04-12 2009-04-29 索尔维亚斯股份公司 Ferrocenediphosphines
CN101479284A (en) * 2006-06-30 2009-07-08 索尔维亚斯股份公司 Diphosphine ligands
CN101861326A (en) * 2007-11-20 2010-10-13 索尔维亚斯股份公司 Bidentate Chiral Ligands for Catalytic Asymmetric Addition Reactions
CN101959898A (en) * 2007-05-10 2011-01-26 尤米科尔股份公司及两合公司 Ruthenium complexes with (P-P)-coordinated ferrocenyldiphosphine ligands, process for preparing them and their use in homogeneous catalysis

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101421285A (en) * 2006-04-12 2009-04-29 索尔维亚斯股份公司 Ferrocenediphosphines
CN101479284A (en) * 2006-06-30 2009-07-08 索尔维亚斯股份公司 Diphosphine ligands
WO2008101868A1 (en) * 2007-02-20 2008-08-28 Solvias Ag Bis (ferrocenylphosphino) ferrocene ligands used in asymmetric hydrogenation reactions
CN101959898A (en) * 2007-05-10 2011-01-26 尤米科尔股份公司及两合公司 Ruthenium complexes with (P-P)-coordinated ferrocenyldiphosphine ligands, process for preparing them and their use in homogeneous catalysis
CN101861326A (en) * 2007-11-20 2010-10-13 索尔维亚斯股份公司 Bidentate Chiral Ligands for Catalytic Asymmetric Addition Reactions

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
STEFFEN TSCHIRSCHWITZ等: "Aminoalkylferrocenyldichlorophosphanes: facile synthesis of versatile chiral starting materials", 《DALTON TRANSCTIONS》, no. 14, 19 February 2007 (2007-02-19), pages 1377 - 1382 *
STEFFEN TSCHIRSCHWITZ等: "Stereoselective Synthesis of ortho-Carbaborane-Containing P-Chiral Phosphanylferrocenes", 《ORGANOMETALLICS》, vol. 26, no. 19, 17 August 2007 (2007-08-17), pages 4715 - 4724 *
聂慧芳等: "合成(R)-(+)-N, N-二甲基-1-二茂铁基乙胺的方法改进", 《合成化学》, vol. 18, no. 6, 20 December 2010 (2010-12-20), pages 760 - 762 *

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103804432A (en) * 2014-02-25 2014-05-21 中国人民解放军第四军医大学 Double-functionalized amine-thiourea organic catalyst based on ferrocene and preparation method and application thereof
CN103831133A (en) * 2014-02-25 2014-06-04 中国人民解放军第四军医大学 Bi-functional phosphine thiourea organic catalyst based on ferrocene skeleton as well as preparation method and application thereof
CN103804432B (en) * 2014-02-25 2017-01-25 中国人民解放军第四军医大学 Double-functionalized amine-thiourea organic catalyst based on ferrocene and preparation method and application thereof
CN104592313A (en) * 2014-12-30 2015-05-06 陕西师范大学 Double functional hydrogen bond organic catalyst based on ferrocene as well as preparation method and application of double functional hydrogen bond organic catalyst
CN104592313B (en) * 2014-12-30 2017-08-25 陕西师范大学 Difunctional hydrogen bond organic catalyst based on ferrocene and its preparation method and application
CN107098932A (en) * 2017-06-29 2017-08-29 管德新 A kind of synthetic method of benzyl class part available for hydroformylation reaction
CN114085251A (en) * 2021-11-02 2022-02-25 中国人民解放军空军军医大学 A class of chiral ferrocene-spiro-ring skeleton bisphosphine ligands and preparation method thereof
CN114085250A (en) * 2021-11-02 2022-02-25 中国人民解放军空军军医大学 Preparation and application of P-chiral phosphine-oxazoline ligand metal complex catalyst containing Ugi's amine building blocks
CN114085251B (en) * 2021-11-02 2024-01-19 中国人民解放军空军军医大学 Chiral ferrocene-spiro framework biphosphine ligand and preparation method thereof
CN114085250B (en) * 2021-11-02 2024-01-19 中国人民解放军空军军医大学 Preparation and application of P-chiral phosphine-oxazoline ligand metal complex catalyst containing Ugi's amine building block
CN116178455A (en) * 2023-04-26 2023-05-30 江苏欣诺科催化剂股份有限公司 Preparation method of ferrocene chiral phosphine ligand
CN116178455B (en) * 2023-04-26 2023-08-18 江苏欣诺科催化剂股份有限公司 Preparation method of ferrocene chiral phosphine ligand

Similar Documents

Publication Publication Date Title
CN103193830A (en) Preparation method of chiral ferrocene phosphine ligand
JP5376743B2 (en) Phosphan ligands with adamantyl groups, their preparation and their use in catalytic reactions
JP4488739B2 (en) P-chiral phosphoranes and phosphocyclic compounds and their use in asymmetric catalysis
CN103012498B (en) Chiral ferrocene tridentate ligand and preparation method thereof and the application in catalysis asymmetry hydrogenation reaction
CN108929345B (en) Chiral ferrocene diphosphine ligand and preparation method and application thereof
Benndorf et al. Synthesis of enantiomeric pure lithium and potassium benzamidinate complexes
Nie et al. Nonepimerizing Alkylation of H–P Species to Stereospecifically Generate P-Stereogenic Phosphine Oxides: A Shortcut to Bidentate Tertiary Phosphine Ligands
US7153809B2 (en) P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
Cortright et al. IAN amines: chiral C 2-symmetric zirconium (IV) complexes from readily modified axially chiral C 1-symmetric β-diketimines
JPH06507175A (en) Chiral tridentate bis(phospholane) ligand
EP2027134B1 (en) Chiral ligands used in transition metal catalysts for asymmetric addition reactions especially hydrogenation
CN109503670B (en) A class of chiral monophosphine ligands WJ-Phos with ferrocene framework and preparation method and application
Damljanović et al. The palladium (II) complex of N, N-diethyl-1-ferrocenyl-3-thiabutanamine: Synthesis, solution and solid state structure and catalytic activity in Suzuki–Miyaura reaction
Edwards et al. Synthesis and application to asymmetric allylic amination of substituted monodonor diazaphospholidine ligands
Li et al. Copper-catalyzed C–P cross-coupling of secondary phosphines with (hetero) aromatic bromide
JP3146187B2 (en) Novel method for producing diphosphine oxide
CN113735899B (en) Synthesis method of compound with phosphine chirality and axial chirality
CN114907404B (en) 5- (2- (Disubstituted phosphino) phenyl) -1-alkyl-1H-pyrazolyl phosphine ligand and preparation method and application thereof
Alame et al. New 5, 5′-disubstituted BINAP derivatives: syntheses and pressure and electronic effects in Rh asymmetric hydrogenation
CN107226829B (en) A kind of preparation method of phosphine oxygen ligand containing ferrocene group
CN109666044B (en) Organophosphorus compound based on [2.2] p-cyclophane alkyl skeleton and intermediate, preparation method and application thereof
CN105949248A (en) Synthesis method of Josiphos chiral ferrocenyl phosphine ligands
WO2009065783A1 (en) Bidentate secondary phosphine oxide chiral ligands for use in asymmetric addition reactions
CN108690074A (en) A kind of double phosphine chipal compounds and preparation method thereof having phosphorus central chirality and axial chiral binaphthyl concurrently
JP3844927B2 (en) Process for producing diphosphine oxide and diphosphonate

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: XI AN INST. OF MODERN CHEMISTRY

Effective date: 20150615

C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20150615

Address after: 710032 Changle West Road, Shaanxi, China, No. 169, No.

Applicant after: The Fourth Military Medical University of the Chinese People's Liberation Army

Applicant after: Xi'an Inst. of Modern Chemistry

Address before: 710032 Changle West Road, Shaanxi, China, No. 169, No.

Applicant before: The Fourth Military Medical University of the Chinese People's Liberation Army

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130710